Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 2/20 | 0.37 |
| ▸ | P2RY12 known ✓ | Q9H244 | 5/20 | 0.33 |
| ▸ | P2RY2 known ✓ | P41231 | 2/20 | 0.31 |
| ▸ | P2RY4 known ✓ | P51582 | 2/20 | 0.31 |
| ▸ | P2RY1 known ✓ | P47900 | 1/20 | 0.31 |
| ▸ | P2RY6 known ✓ | Q15077 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | PTPRC | P08575 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16490257 | 0.87 | KDM4E (0.38) | THRBMEN1POLBPTPN1KMT2A | |
| SCHEMBL19322466 | 0.87 | KDM4E (0.38) | THRBMEN1POLBPTPN1KMT2A | |
| SCHEMBL30256044 | 0.87 | KDM4E (0.38) | THRBMEN1POLBPTPN1KMT2A | |
| SCHEMBL21436647 | 0.82 | P2RY4 (0.41) | THRBMEN1POLBPTPN1KMT2A | |
| SCHEMBL341772 | 0.82 | CES1 (0.36) | THRBMEN1POLBPTPN1KMT2A | |
| SCHEMBL340899 | 0.81 | THRB (0.34) | THRBMEN1POLBKMT2AALDH1A1 | |
| SCHEMBL31679136 | 0.81 | THRB (0.34) | THRBMEN1POLBKMT2AALDH1A1 | |
| SCHEMBL21436270 | 0.81 | P2RY4 (0.37) | THRBMEN1POLBPTPN1KMT2A | |
| SCHEMBL9105169 | 0.80 | CES1 (0.36) | THRBMEN1POLBPTPN1KMT2A | |
| SCHEMBL9106048 | 0.80 | CES1 (0.36) | THRBMEN1POLBPTPN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250108658-A1 | INKJET PRINTING PROCESSES FOR TEMPORARY TATTOOS | Prism Inks, Inc. (US) | 2025-04-03 | — | — | US | disclosed |
| WO-2022188373-A1 | METHOD FOR DETECTING WATER-SOLUBLE ANIONIC SYNTHETIC PIGMENT IN FOOD | 广州市食品检验所（广州市酒类检测中心） | 2022-09-15 | — | — | WO | disclosed |
| EP-2710996-B1 | Sunscreen compositions comprising colour pigments | BASF SE (DE) | 2022-08-17 | — | — | EP | disclosed |
| US-11384033-B2 | Compositions with improved urease-inhibiting effect comprising (thio)phosphoric acid triamide and further compounds such as amines and colorants | BASF SE (DE) | 2022-07-12 | — | — | US | disclosed |
| CN-107108388-B | Composition comprising (thio) phosphoric triamide and other compounds such as amines and colorants with improved urease-inhibiting effect | 巴斯夫欧洲公司 | 2021-02-26 | — | — | CN | disclosed |
| CN-112374933-A | Composition comprising (thio) phosphoric triamide and other compounds such as amines and colorants with improved urease-inhibiting effect | 巴斯夫欧洲公司 | 2021-02-19 | — | — | CN | disclosed |
| EP-3763692-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO) PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | BASF SE (DE) | 2021-01-13 | — | — | EP | disclosed |
| EP-3763691-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO)PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | BASF SE (DE) | 2021-01-13 | — | — | EP | disclosed |
| EP-3725756-A2 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING AMINES, OR COLORANTS, AND AN ADDUCT OF THE THREE COMPOUNDS N-(N-BUTYL) THIOPHOSPHORIC ACID TRIAMIDE (NBPT), UREA, AND FORMALDEHYDE | BASF SE (DE) | 2020-10-21 | — | — | EP | disclosed |
| US-20200157018-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO)PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | BASF SE (DE) | 2020-05-21 | — | — | US | disclosed |
| US-7651661-B2 | Medical devices with broad spectrum antimicrobial activity | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-01-26 | — | — | US | disclosed |
| US-20080183152-A1 | MEDICAL DEVICES WITH BROAD SPECTRUM ANTIMICROBIAL ACTIVITY | RAAD ISSAM | 2008-07-31 | — | — | US | disclosed |
| US-20070154621-A1 | METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2007-07-05 | — | — | US | disclosed |
| US-20050197634-A1 | Methods for coating and impregnating medical devices with antiseptic compositions | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2005-09-08 | — | — | US | disclosed |
| EP-1440319-A2 | AN IMPROVED METHOD TO DETECT INTERACTIONS BETWEEN CELLULAR COMPONENTS IN INTACT LIVING CELLS, AND TO EXTRACT QUANTITATIVE INFORMATION RELATING TO THOSE INTERACTIONS BY FLUORESCENCE REDISTRIBUTION | BioImage A/S (DK) | 2004-07-28 | — | — | EP | disclosed |
| US-20030162165-A1 | Chemical signal enhancement of dynamic intensity-based intracellular protein-and fluorophore-based redistribution assays for drug-screening | BIOIMAGE A/S (DK) | 2003-08-28 | — | — | US | disclosed |
| US-20030143634-A1 | Method to detect interactions between cellular components in intact living cells, and to extract quantitative information relating to those interactions by fluorescence redistribution | BIOLMAGE A/S (DK) | 2003-07-31 | — | — | US | disclosed |
| WO-2003029827-A2 | A METHOD OF DETECTING INTRACELLULAR PROTEIN-PROTEIN INTERACTIONS USING THREE HETEROLOGOUS CONJUGATES | BIOIMAGE A/S (DK) | 2003-04-10 | — | — | WO | disclosed |
| EP-1279037-A2 | CHEMICAL SIGNAL ENHANCEMENT OF DYNAMIC INTENSITY-BASED INTRACELLULAR PROTEIN- AND FLUOROPHORE-BASED REDISTRIBUTION ASSAYS FOR DRUG SCREENING | BioImage A/S (DK) | 2003-01-29 | — | — | EP | disclosed |
| WO-2001081917-A2 | CHEMICAL SIGNAL ENHANCEMENT OF DYNAMIC INTENSITY-BASED INTRACELLULAR PROTEIN- AND FLUOROPHORE-BASED REDISTRIBUTION ASSAYS FOR DRUG SCREENING | BIOIMAGE A/S (DK) | 2001-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200157018-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO)PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | SLC14A1, XDH, PNP | THRB 972/4885P2RY12 486/4885P2RY2 539/4885 |
| US-11384033-B2 | Compositions with improved urease-inhibiting effect comprising (thio)phosphoric acid triamide and further compounds such as amines and colorants | SLC14A1, XDH, PNP | THRB 972/4885P2RY12 486/4885P2RY2 539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.